Dipna Pharmachem
BSE: DPL · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Dipna Pharmachem's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Dipna Pharmachem Limited is an Ahmedabad-based trading and distribution company specialising in pharmaceutical raw materials, active pharmaceutical ingredients, and industrial chemicals. It functions as a supply chain intermediary, sourcing products from manufacturers to supply formulation companies across India.
Business Model
The company operates as a trading entity, generating revenue through the procurement and distribution of chemical products and pharmaceutical excipients. Its model relies on efficient inventory management and leveraging an established network of suppliers and customers.
Management Commentary
Management focuses on maintaining a strong market presence within the competitive chemical distribution sector while prioritising the expansion of its product basket.
Growth Outlook
Growth is driven by the strategic expansion of the company's product portfolio to cater to increasingly diverse industrial requirements. The firm continues to leverage its distribution logistics to capture demand from formulation companies.
Key Risks
- Supply Chain Volatility. As a trading entity, the company is vulnerable to fluctuations in the availability and pricing of raw materials from its suppliers.
- Regulatory Compliance. The pharmaceutical distribution sector is subject to stringent quality and safety regulations that may impact operational costs if standards change.
- Market Competition. The chemical distribution industry is highly fragmented and competitive, which may exert pressure on profit margins.
- Inventory Risk. Reliance on inventory management exposes the company to risks associated with price volatility and potential obsolescence of chemical stocks.
Start your research today
Unlock AI insights, financials, peers and live data on Dipna Pharmachem and 5,000+ companies — free.
Peers · Pharmaceuticals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Dipna PharmachemDPL | ₹14 Cr | — | — | — | 4.0% | — | — | -72.1% |
Albert DavidALBERTDAVD | ₹513 Cr | 22.73 | 13.48 | 11.4% | 11.0% | 5.8% | 7.5% | +12.1% |
Jenburkt Pharmaceuticals LimitedJENBURPH | ₹463 Cr | 13.31 | 8.46 | — | 32.0% | 17.6% | 23.2% | -4.3% |
Haleos Labs LimitedHALEOSLABS | ₹452 Cr | 28.60 | 12.72 | -3.1% | 13.6% | 7.4% | 10.3% | — |
TranschemTRANSCHEM | ₹424 Cr | 98.76 | 68.07 | -100.0% | 177.7% | 5.3% | 7.0% | +592.6% |
Medicamen BiotecMEDICAMEQ | ₹338 Cr | 33.59 | 15.53 | 24.7% | 11.3% | 4.1% | 6.2% | -27.9% |
As of Mar 2026
Financials
Dipna Pharmachem
BSE: DPL · Pharmaceuticals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock Dipna Pharmachem's vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Dipna Pharmachem Limited is an Ahmedabad-based trading and distribution company specialising in pharmaceutical raw materials, active pharmaceutical ingredients, and industrial chemicals. It functions as a supply chain intermediary, sourcing products from manufacturers to supply formulation companies across India.
Business Model
The company operates as a trading entity, generating revenue through the procurement and distribution of chemical products and pharmaceutical excipients. Its model relies on efficient inventory management and leveraging an established network of suppliers and customers.
Management Commentary
Management focuses on maintaining a strong market presence within the competitive chemical distribution sector while prioritising the expansion of its product basket.
Growth Outlook
Growth is driven by the strategic expansion of the company's product portfolio to cater to increasingly diverse industrial requirements. The firm continues to leverage its distribution logistics to capture demand from formulation companies.
Key Risks
- Supply Chain Volatility. As a trading entity, the company is vulnerable to fluctuations in the availability and pricing of raw materials from its suppliers.
- Regulatory Compliance. The pharmaceutical distribution sector is subject to stringent quality and safety regulations that may impact operational costs if standards change.
- Market Competition. The chemical distribution industry is highly fragmented and competitive, which may exert pressure on profit margins.
- Inventory Risk. Reliance on inventory management exposes the company to risks associated with price volatility and potential obsolescence of chemical stocks.
Start your research today
Unlock AI insights, financials, peers and live data on Dipna Pharmachem and 5,000+ companies — free.
Peers · Pharmaceuticals
As of Mar 2026